Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W9BH
|
|||
| Former ID |
DNC009765
|
|||
| Drug Name |
N-Hydroxy-E-3-(4'-cyanobiphenyl-4-yl)-acrylamide
|
|||
| Synonyms |
CHEMBL538710; SCHEMBL3292721; SCHEMBL3292715; BDBM50293355
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12N2O2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C=CC(=O)NO)C2=CC=C(C=C2)C#N
|
|||
| InChI |
1S/C16H12N2O2/c17-11-13-3-8-15(9-4-13)14-6-1-12(2-7-14)5-10-16(19)18-20/h1-10,20H,(H,18,19)/b10-5+
|
|||
| InChIKey |
NJUOLWKIAIFTKT-BJMVGYQFSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. Eur J Med Chem. 2009 May;44(5):1900-12. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.